Mylan Pharmaceuticals Inc. v. Galderma Laboratories Inc. et al > Summary
Court Case Number 1:10-cv-00892
Filing Date Oct 18, 2010
Court Delaware District Court
Status Unknown
Plaintiff
Plaintiff Attorneys
12Viatris Inc.
Attorney Name: Michael A. Berta
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Kirin K. Gill
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Richard L. Horwitz
Potter Anderson & Corroon
Viatris Inc.
Attorney Name: Terrence Kearney
Latham & Watkins
Viatris Inc.
Attorney Name: Tung-On Kong
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Melissa Kopacz
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: David E. Moore
Potter Anderson & Corroon
Viatris Inc.
Attorney Name: Michael D. K. Nguyen
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Matthew R. Reed
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Ron E. Shulman
Latham & Watkins
Viatris Inc.
Attorney Name: David S. Steuer
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Lorelei P. Westin
Wilson Sonsini Goodrich & Rosati
Defendant Attorneys
6Galderma Laboratories
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Supernus Pharmaceuticals
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Galderma Laboratories
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Galderma Laboratories
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Supernus Pharmaceuticals
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Counter Defendant
2Viatris Inc.
Attorney Name: Richard L. Horwitz
Potter Anderson & Corroon
Viatris Inc.
Attorney Name: David E. Moore
Potter Anderson & Corroon
Counter Claimant
3Cause
28:1331 Fed. Question
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07232572 | Methods of treating rosacea | Jun 19, 2007 |
| 07211267 | Methods of treating acne | May 1, 2007 |
| 05919775 | Method for inhibiting expression of inducible nitric oxide synthase with tetracycline | Jul 6, 1999 |
| 05789395 | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production | Aug 4, 1998 |
